Press release
Bile Duct Cancer Market Ready to Hit at a CAGR of 9.2% by 2023 | Pfizer, F. Hoffmann-La Roche, Bristol-Myers Squibb, etc till 2023
Market Research Future published a research report on Global Bile Duct Cancer Market and Provide Market analysis, size, share and future growth of industry. The Global Bile Duct Cancer Market is expected to grow at an approximate CAGR of 9.1% during the forecast period. Report provide unique information which is unavailable on any other source and forecast up to 2023Bile duct cancer or cholangiocarcinoma is a rare form of cancer occurring due to uncontrolled growth of abnormal cells within the bile ducts, which can affect surrounding healthy tissues and organs like pancreas and can eventually spread to other areas in the body. Bile duct cancer can be diagnosed by imaging tests, blood test, abdominal ultrasound, biopsy of the affected tissue and other methods.
According to the American cancer society, 30,200 estimated deaths have occurred in U.S in 2017 and 42,220 new cases of intrahepatic bile duct cancer are expected to occur in U.S. in 2018 .The growing prevalence of bile duct cancer is likely to boost the market in forecast period.
The Global Bile Duct Cancer Market accounted to USD 154.5 million in 2017 and is forecasted to demonstrate a radial growth by 2018, Global Bile Duct market is expected to grow at a CAGR of 9.1% during forecasted period 2018-2023.
Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/4741 .
Key players for Global Bile Duct Cancer Market
The key players for the Global Bile Duct Cancer Market are Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd (Europe), Teva Pharmaceutical Industries Ltd.(Israel), Eli Lilly and Company(U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), Pfizer Inc.(US), Johnson & Johnson (U.S.), Celgene Corporation(U.S.) and others.
Competitive Landscape of Global Bile Duct Cancer Market
The Global Bile Duct Cancer Market appears to be highly fragmented and highly competitive due to new product launches and increasing clinical research. The key player have developed strategic approaches to increase their foothold in this market. The major key players are located in North America region like Pfizer Inc., Bristol-Myers Squibb Company increasing the market revenue in the region.
Pfizer Inc. is an American Global research based pharmaceutical company with its headquarter in New York City. Pfizer is engaged in developing, producing and manufacturing healthcare products. The major sector includes immunology, oncology, cardiology, endocrinology, and neurology. Pfizer Inc. has two business segments, Pfizer Innovative Health and Pfizer Essential Health. The company has its market in over 125 countries.
Eli Lilly and Company is a leading Global pharmaceutical corporation headquartered in Indiana, U.S. with its product sold in over 120 countries and manufacturing plants located in 17 countries. The company operates in two segments human pharmaceutical and animal healthcare. The human pharmaceutical segment includes immunology products, endocrinology products, neuroscience products, oncology products, and cardiovascular products. The Company's major oncology products include Altima, Cyramza, Gemzar, and Portrazza.
In March 2018, Eli Lilly and Company announced successful completion of its primary phase 3 REACH-2 trial study in trial biomarker selected population for CYRAMZA (ramucirumab), a single agent in the second-line treatment of people with hepatocellular carcinoma (HCC).The trial met its primary and secondary endpoint. This study proves beneficial for the company as CYRAMZA has demonstrated survival benefits in four regressive tumor type and as single agent in hepatocellular carcinoma.
Get an Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/4741 .
Segmentations for Global Bile Duct Cancer Market
The Global Bile Duct Cancer Market is segmented on the basis of types, diagnosis, treatment, and end users.
On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.
On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.
On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.
On the basis of end users, the market is segmented into hospital &clinics, academic institutes, research organizations and others.
Some Brief Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
TOC Continued…
LIST OF TABLES
Table 1 Bile Duct Cancer Industry Synopsis, 2017 – 2023
Table 2 Global Bile Duct Cancer Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Bile Duct Cancer Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)
Table 5 Global Bile Duct Cancer Market By Diagnosis, 2017 – 2023, (USD Million)
Table 6 Global Bile Duct Cancer Market By Treatment, 2017 – 2023, (USD Million)
Table 7 Global Bile Duct Cancer Market By End Users, 2017 – 2023, (USD Million)
Table 8 North America Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)
Continued…
Access Complete Report @ https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bile Duct Cancer Market Ready to Hit at a CAGR of 9.2% by 2023 | Pfizer, F. Hoffmann-La Roche, Bristol-Myers Squibb, etc till 2023 here
News-ID: 1064148 • Views: …
More Releases from Market Research Future
Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Du …
Denim Market Size Grow at a 75.25 USD Billion in 2025 to 132.4 USD Billion by 2035, CAGR of 5.81% By 2025 - 2035
Global Denim Market is entering a new phase of transformation as consumer demand, fashion cycles, and sustainable innovation continue to reshape the industry. Denim, once considered a classic wardrobe staple, has evolved into a versatile, fashion-driven category supported by innovations in fabric technology, eco-friendly production, and shifting…
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% …
The global Humanoid Robots Market is projected to reach USD 13.8 Billion by 2032, growing at a robust CAGR of 50.2% during the forecast period from 2024 to 2032.
Driven by advancements in artificial intelligence, machine learning, and machine vision, humanoid robots-designed with human-like characteristics-are witnessing widespread adoption across healthcare, education, space exploration, and service industries. These robots are enhancing operational efficiency, performing complex tasks, and improving customer engagement across multiple…
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.8 …
The Vertical Farming Market was estimated at USD 7.48 Billion in 2024 and is projected to grow from USD 9.023 Billion in 2025 to USD 58.83 Billion by 2035, exhibiting a robust CAGR of 20.62% during the forecast period from 2025 to 2035.
Driven by increasing demand for sustainable agriculture, urbanization, and technological advancements in controlled-environment farming, vertical farming solutions are seeing widespread adoption across commercial, industrial, and urban agriculture sectors.
Key…
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to H …
The Robotics Market was valued at USD 74,120.70 Million in 2024 and is projected to reach USD 476,019.67 Million by 2035, growing at a robust CAGR of 18.4% during the forecast period from 2024 to 2035.
Driven by advancements in medical robots, growing industrial robotics adoption, and the development of AI technologies, robotics solutions are witnessing widespread adoption across healthcare, manufacturing, logistics, and service sectors. Despite challenges like high initial costs…
More Releases for Bile
Global Bile Acid Market Outlook Report 2025
On Aug 22, Global Info Research released "Global Bile Acid Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report includes an overview of the development of the Bile Acid industry chain, the market status of Bile Acid Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Bile Acid.
According to our (Global Info Research) latest…
Bile Duct Cancer Market Outlook: Diagnosis, Therapies, and Innovations
Bile Duct Cancer Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing…
OX Bile Extract Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on OX Bile Extract Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the OX Bile Extract market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.…
Bile Duct Cancer Drugs and Companies Research 2023
Report Description
This report analyzes the bile duct cancer market by type (intrahepatic, extrahepatic), diagnosis (blood tests, abdominal imaging, surgery), by treatment (chemotherapy, radiotherapy), by end user (hospital& clinics, academic institutes); it also studies the top manufacturers in the market.
The bile duct cancer market is expected to grow at a CAGR of near about 9.2% during the forecast period.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3439013-bile-duct-cancer-market-research-report-global-forecast-till-2023
The major players in bile duct cancer…
Bile Duct Cancer Market Overview and Report forecast 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…
Bile Duct Cancer Market Size – Industry Share Report 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…
